Goldman Sachs Maintains Neutral on Stryker, Lowers Price Target to $357

Benzinga Newsdesk www.benzinga.com Negative 73.5%

Neg 73.5% Neu 0% Pos 0%

Goldman Sachs analyst David Roman maintains Stryker (NYSE:SYK) with a Neutral and lowers the price target from $403 to $357.